Integrating genetics with newborn metabolomics in infantile hypertrophic pyloric stenosis

[1]  John A. Bowden,et al.  International Ring Trial of a High Resolution Targeted Metabolomics and Lipidomics Platform for Serum and Plasma Analysis. , 2019, Analytical chemistry.

[2]  J. Oleson,et al.  Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population‐based retrospective study, 1999–2010 , 2018, Birth defects research.

[3]  D. Hougaard,et al.  Genome-wide meta-analysis identifies BARX1 and EML4-MTA3 as new loci associated with infantile hypertrophic pyloric stenosis , 2018, Human molecular genetics.

[4]  A. Pottegård,et al.  The Danish Medical Birth Register , 2018, European Journal of Epidemiology.

[5]  Y. Qu,et al.  Perinatal risk factors for infantile hypertrophic pyloric stenosis: A meta-analysis. , 2017, Journal of pediatric surgery.

[6]  Jerzy Adamski,et al.  Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma. , 2017, Analytical chemistry.

[7]  B. Koletzko,et al.  Phospholipid Species in Newborn and 4 Month Old Infants after Consumption of Different Formulas or Breast Milk , 2016, PloS one.

[8]  Christian Gieger,et al.  Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels , 2015, Nature Communications.

[9]  D. Dunger,et al.  Lipidomic Analyses, Breast- and Formula-Feeding, and Growth in Infants , 2015, The Journal of pediatrics.

[10]  P. Rzehak,et al.  Dietary protein intake affects amino acid and acylcarnitine metabolism in infants aged 6 months. , 2015, The Journal of clinical endocrinology and metabolism.

[11]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[12]  B. Feenstra,et al.  Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study , 2014, BMJ : British Medical Journal.

[13]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[14]  A. Goldin,et al.  Role of bottle feeding in the etiology of hypertrophic pyloric stenosis. , 2013, JAMA pediatrics.

[15]  B. Feenstra,et al.  Plasma lipids, genetic variants near APOA1, and the risk of infantile hypertrophic pyloric stenosis. , 2013, JAMA.

[16]  J. Adamski,et al.  Targeted Metabolomics of Dried Blood Spot Extracts , 2013, Chromatographia.

[17]  R. Biggar,et al.  Bottle-feeding and the Risk of Pyloric Stenosis , 2012, Pediatrics.

[18]  R. Biggar,et al.  Pre- and perinatal risk factors for pyloric stenosis and their influence on the male predominance. , 2012, American journal of epidemiology.

[19]  D. Vance,et al.  Phosphatidylcholine biosynthesis and lipoprotein metabolism. , 2012, Biochimica et biophysica acta.

[20]  D. Hougaard,et al.  Common variants near MBNL1 and NKX2-5 are associated with infantile hypertrophic pyloric stenosis , 2012, Nature Genetics.

[21]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[22]  Elsebeth Lynge,et al.  The Danish National Patient Register , 2011, Scandinavian journal of public health.

[23]  Gary L Hoffman,et al.  Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project , 2011, Genetics in Medicine.

[24]  K. Christensen,et al.  Familial aggregation and heritability of pyloric stenosis. , 2010, JAMA.

[25]  E. Chung.  Infantile hypertrophic pyloric stenosis: genes and environment , 2008, Archives of Disease in Childhood.

[26]  Christian Gieger,et al.  Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum , 2008, PLoS genetics.

[27]  M. Loane,et al.  Infantile hypertrophic pyloric stenosis: A comparative study of incidence and other epidemiological characteristics in seven European regions , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[28]  D. Hougaard,et al.  Storage policies and use of the Danish Newborn Screening Biobank , 2007, Journal of Inherited Metabolic Disease.

[29]  B. Macmahon.  The Continuing Enigma of Pyloric Stenosis of Infancy: A Review , 2006, Epidemiology.

[30]  S. Lahav,et al.  A Comparison of Intakes of Breast-Fed and Bottle-Fed Infants during the First Two Days of Life , 2001, Journal of the American College of Nutrition.

[31]  C. Agostoni,et al.  Free Amino Acid Content in Standard Infant Formulas: Comparison with Human Milk , 2000, Journal of the American College of Nutrition.

[32]  R. Hennekam,et al.  The Smith-Lemli-Opitz syndrome , 2000, Journal of Medical Genetics.

[33]  G Salen,et al.  Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. , 1994, The New England journal of medicine.

[34]  M. Neville,et al.  Nutrient intake by breast-fed infants during the first five days after birth. , 1986, American journal of diseases of children.

[35]  L. Carlson,et al.  Sex differences in serum lipids and lipoproteins at birth , 1977, European journal of clinical investigation.

[36]  J. Kopple,et al.  Evidence that histidine is an essential amino acid in normal and chronically uremic man. , 1975, The Journal of clinical investigation.